Search clinical trials for: Erythropoietin and Hydroxyurea

Total 270322 results

Sheri Kashmir Institute of Medical Sciences

Completed

Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

Perinatal Asphyxia

India
North Texas Veterans Healthcare System

Completed

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

Acute Kidney Injury

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Chronic Kidney Disease | Sickle Cell Disease | Pulmonary Hypertension

United States
Julia Xu
Carnegie Mellon University; American Society of Hematology

Recruiting

Hydroxyurea and EPO in Sickle Cell Disease (ACHiEvE-SCD)

Sickle Cell Disease | Anemia, Sickle Cell

United States, Nigeria
Shiraz University of Medical Sciences

Completed

Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia

β-Thalassemia Intermedia

Iran, Islamic Republic of
University of Cambridge
Hoffmann-La Roche; Roche Foundation of Anemia Research (RoFAR, Switzerland)

Completed

Erythropoietin Therapy for Subarachnoid Hemorrhage

Aneurysmal Subarachnoid Hemorrhage

United Kingdom
Peking University

Unknown

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma | Anemia | Hematopoietic Stem Cell Transplantation

China
Bundang CHA Hospital
LG Life Sciences

Completed

Erythropoietin Therapy for Children With Cerebral Palsy

Cerebral Palsy

Korea, Republic of
Chugai Pharmaceutical

Completed

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Chemotherapy Induced Anemia
Vanderbilt University Medical Center
Aminu Kano Teaching Hospital; Murtala Muhammed Specialist Hospital

Completed

Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa (SPRINT)

Stroke | Sickle Cell Disease | Sickle Cell Anemia

Nigeria
Angde Biotech Pharmaceutical Co., Ltd.

Recruiting

A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .

Renal Anemia

China
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants (EPO)

Anemia, Neonatal | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
Fatih Sultan Mehmet Training and Research Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital

Completed

Proliferative Effects of Erythropoietin on Human Endometrium

Anemia | Endometrial Diseases

Turkey
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Chronic Renal Failure

China
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Leukemia

United States
Ain Shams University

Unknown

Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.

Thalassemia Intermedia

Egypt
VA Office of Research and Development

Terminated

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

Atherosclerosis | Anemia | CKD | Cardiovascular

United States
Vanderbilt University Medical Center
National Institute of Neurological Disorders and Stroke (NINDS); Aminu Kano... and other collaborators

Completed

Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II (SPRING)

Stroke | Sickle Cell Disease

Nigeria
Tianjin SinoBiotech Ltd.

Completed

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

Healthy Subjects

China
Shenzhen Second People's Hospital

Recruiting

Roxadustat for Anemia in Patients With CKD

Anemia of Chronic Kidney Disease

China
Italfarmaco

Completed

Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera (PV)

Polycythemia Vera

Italy
St. Jude Children's Research Hospital

Terminated

Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere

Sickle Cell Disease | Thalassemia

United States
UNICANCER

Completed

Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

Brain and Central Nervous System Tumors

France
St. Jude Children's Research Hospital

Completed

Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

Lymphoma

United States
National Institute of Neurological Disorders and...

Withdrawn

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in People With Persistent Symptoms During the Subacute Period After Traumatic Brain Injury

Traumatic Brain Injury
Mathew S. Maurer
National Institute on Aging (NIA)

Completed

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)

Anemia

United States
Northwestern University

Active, not recruiting

Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

Liver Transplant Rejection

United States
Alexandria University

Completed

Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

Optic Neuropathy

Egypt
Sanquin Research & Blood Bank Divisions
ZonMw: The Netherlands Organisation for Health Research and Development; Roche... and other collaborators

Completed

Blood Management in Orthopedic Surgery (TOMaat)

Osteoarthritis

Netherlands
St. Jude Children's Research Hospital

Completed

Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease

Anemia, Sickle Cell

United States
Duke University

Completed

Hydroxyurea in Young Children With Sickle Cell Anemia

Sickle Cell Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)

Hematologic Diseases | Anemia, Sickle Cell | Hemoglobinopathies
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group

Completed

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Adult Meningioma

United States
American Regent, Inc.

Completed

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

Anemia
Assiut University

Unknown

Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS

MDS
Hospital Authority, Hong Kong
The Hong Kong Society of Nephrology

Completed

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

Cardiovascular Diseases | Kidney Diseases | Chronic Disease

China
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course

- Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)

France
Loyola University
University of Illinois at Chicago; University of Ibadan

Completed

Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment

Sickle Cell Disease | Sickle Cell Anemia

Nigeria
ADDMEDICA SASA

Completed

Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)

Sickle Cell Disease | Renal Function Disorder

France
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

Hematologic Diseases | Anemia, Sickle Cell | Hemoglobinopathies
Vion Pharmaceuticals

Completed

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms

United States, France, United Kingdom
Bio Sidus SA

Unknown

Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease

Anemia of Chronic Kidney Disease

Argentina, Paraguay
Hospital General de Niños Pedro de Elizalde

Completed

Erythropoietin in Hemolytic Uremic Syndrome

Anemia | Hemolytic-Uremic Syndrome

Argentina
Medical College of Wisconsin

Withdrawn

Erythropoietin Effects After Traumatic Brain Injury

Traumatic Brain Injury

United States
Northwestern University
Icahn School of Medicine at Mount Sinai; Mount Sinai Hospital, New York

Completed

Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease

Autoimmune Hepatitis

United States
Mahidol University

Completed

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients (CUAEPO)

Chronic Renal Failure

Thailand
Kyoto Prefectural University of Medicine

Unknown

Anti-Restenosis After AMI by Erythropoietin

Acute Myocardial Infarction

Japan
Hammersmith Hospitals NHS Trust

Unknown

Erythropoietin in Acute Myocardial Infarction

Acute Myocardial Infarction

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated (HYDREP)

Drepanocytic Men Treated by Hydroxyurea for the First Time

France
Duke University
Novartis Pharmaceuticals

Completed

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Glioblastoma | Gliosarcoma

United States

Search clinical trials for: Erythropoietin and Hydroxyurea

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations